Close Search
Legal

IP for Life Sciences Roundtable

Ritz Carlton, Boston, MA

September 14, 2021

Intangible assets are the crown jewels of the world’s most valuable life sciences companies.

Today’s IP executives face seemingly limitless opportunities to leverage intangible assets, with a commensurate volume of threats. As a result, they must be as informed, nimble, and forward-thinking as any corporate leaders, for the success of their companies and the improvement of life across the globe.

Topics for discussion include:

  • Resiliency: Taking A Closer Look At The Role Of The IP Leader Over The Past Year
  • Collaboration Is Key: Navigating The Partnership Between Commercial & IP Legal Teams
  • Enhancing Your Research & Development Pipeline

Advisory Board:

  • Bryan Boyle Vice President, Legal Alkahest
  • Kerri Braun Deputy General Counsel, Intellectual Property Kids II
  • Jeffrey Butler Head of Intellectual Property, Biotechnology Lonza
  • Jennifer Chung Chief Intellectual Property Counsel Accuweather
  • Colm Dobbyn Group Executive and Associate General Counsel, Intellectual Property MasterCard
  • David Dutcher Chief Patent Counsel Western Digital
  • Jesse Fecker Senior Director, Chief U.S. Patent Counsel Ferring Pharmaceuticals
  • Berrie Goldman Intellectual Property Lead Invitae
  • Colin Heitzmann Senior Corporate Attorney, Legal Affairs Otsuka Pharmaceuticals
  • Chris Lhulier Assistant Chief Intellectual Property Counsel DuPont
  • Heidi Martinez Chief Intellectual Property Counsel Xerox
  • Kevin McGough Vice President, Intellectual Property Takeda
  • Shaun Montana Chief Intellectual Property Counsel Osram Sylvania
  • Bruce Wu Vice President, Intellectual Property Nutcracker Therapeutics, Inc.
  • Ashley Zito Chief Intellectual Property Counsel IHG

 

Please view Consero’s health and safety protocols for in-person events here.

 

Critical Voices, Exceptional Dialogue

Hear from and interact with some of the most influential voices in this space.

Brenda Jarrell

Co-Chair of Life Sciences and IP Groups

Choate Hall & Stewart

Kent Robbins

Co-Chair of Life Sciences and IP Groups

Murgitroyd

Julie Anne Gillespie

Head of Intellectual Property

BioNTech US, Inc

Elbert Chiang

Sr. Director, Head, Intellectual Property

Beam Therapeutics

Forrester Liddle

Director, Intellectual Property

Jounce Therapeutics

Karen Brown

SVP, IP & Legal Affairs

Prime Medicine, Inc.

John Keyes

Chief Intellectual Property Counsel

Conagen

Jennifer Loebach

Vice President, Intellectual Property

Blueprint Medicines Corporation

Chandra Adams

Vice President, Legal

Surface Oncology, Inc.

Tom McLean

VP of Intellectual Property

Relay Therapeutics

Christopher Verni

Senior Vice President, Deputy General Counsel, Chief Intellectual Property Officer

Sarepta Therapeutics

Ljiljana Minwalla

Senior Vice President, Intellectual Property & Legal Affairs

Cygnal Therapeutics

Hilary Libka

Chief IP Counsel and Associate General Counsel

Dana-Farber Cancer Institute, Inc.

Steve Bossone

Senior Vice President and Chief Patent Counsel

Alnylam Pharmaceuticals

Eden Stright

Director, US Managed Services Support Group

Murgitroyd

Our Event Partners

Related Upcoming Events

From virtual activations to forums and roundtables at destinations across the country, Consero adapts to serve its attendees. Here’s what’s coming up within your field.

Request an Invitation